Dopaminergic inhibition of secretin-stimulated choleresis by increased PKC-gamma expression and decrease of PKA activity. [electronic resource]
Producer: 20030428Description: G683-94 p. digitalISSN:- 0193-1857
- 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine -- pharmacology
- Acetophenones -- pharmacology
- Alkaloids
- Animals
- Benzophenanthridines
- Benzopyrans -- pharmacology
- Bicarbonates -- metabolism
- Bile -- metabolism
- Bile Ducts, Intrahepatic -- cytology
- Chelating Agents -- pharmacology
- Cyclic AMP -- metabolism
- Cyclic AMP-Dependent Protein Kinases -- metabolism
- Dopamine -- metabolism
- Dopamine Agonists -- pharmacology
- Down-Regulation -- drug effects
- Egtazic Acid -- analogs & derivatives
- Enzyme Inhibitors -- pharmacology
- Epithelium -- enzymology
- Liver -- enzymology
- Male
- Phenanthridines -- pharmacology
- Protein Kinase C -- genetics
- Quinolines -- pharmacology
- Rats
- Rats, Inbred F344
- Receptors, Dopamine D2 -- metabolism
- Secretin -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.